CD274 and hepatocellular carcinoma: Additionally, EV-loaded CD38 siRNA decreases the production of immunosuppressive metabolite adenosine and promotes the differentiation of TAMs toward the M1 phenotype, which represses HCC growth and metastasis while reversing tolerance to anti-PD-1/PD-L1 treatment[40].